Most patient on GLP-1 medications notice their appetite slowly decrease while feeling full sooner at meal time
Some people find tirzepatide easier to tolerate, while others have a smoother experience on semaglutide a variability driven by factors like genetics, diet, and individual dose escalation protocols
Semaglutide may be the right starting point if you: Are new to GLP-1 therapy and want to start with the most established option Have a moderate amount of weight to lose Don't have significant insulin resistance or type 2 diabetes Want a well-documented safety profile with years of real-world data Tirzepatide may be the stronger option if you: Have a higher BMI or significant amount of weight to lose Have insulin resistance, prediabetes, or type 2 diabetes Have tried Semaglutide previously with limited results Want the most aggressive metabolic intervention currently available Are dealing with significant visceral fat or metabolic syndrome The Most Important Factor: Medical Guidance The right medication is the one your provider determines is appropriate for your health history, labs, BMI, and goals not the one that sounds more advanced or that someone else is using
A diabetes drug is a weight-loss drug is a cardiovascular drug is, possibly, a neuroprotective drug
In one example reviewed by Guardian Australia, the site Greatrfg.com uses an Australian flag banner and sells a GLP-1 Oral Solution For Weight Reduction
Semaglutide Both Tirzepatide and Semaglutide are helpful for weight loss and blood sugar control
